Altimmune

Beleggen in aandelen beurs New York, Dow Jones, Nasdaq-100 en S&P500
Plaats reactie



believer
Forum elite
Forum elite
Berichten: 6451
Lid geworden op: 14 jan 2015 17:30
waarderingen: 4669

Altimmune

Bericht door believer »

Onlangs goeie fase 2 resultaten gebracht, overname of deals in een miljardenmarkt, notering onder ALT

https://www.reuters.com/business/health ... 023-12-05/


believer
Forum elite
Forum elite
Berichten: 6451
Lid geworden op: 14 jan 2015 17:30
waarderingen: 4669

Re: Altimmune

Bericht door believer »


believer
Forum elite
Forum elite
Berichten: 6451
Lid geworden op: 14 jan 2015 17:30
waarderingen: 4669

Re: Altimmune

Bericht door believer »


believer
Forum elite
Forum elite
Berichten: 6451
Lid geworden op: 14 jan 2015 17:30
waarderingen: 4669

Re: Altimmune

Bericht door believer »


believer
Forum elite
Forum elite
Berichten: 6451
Lid geworden op: 14 jan 2015 17:30
waarderingen: 4669

Re: Altimmune

Bericht door believer »

Drugs in the pipeline - including Lilly's retatrutide; Novo's CagriSema, a once-monthly injection in development at Amgen Inc. (AMGN); and Altimmune's pemvidutide - are "really, really exciting," Apovian said, because they're demonstrating great weight-loss benefits using some different mechanisms than drugs currently on the market."

believer
Forum elite
Forum elite
Berichten: 6451
Lid geworden op: 14 jan 2015 17:30
waarderingen: 4669

Re: Altimmune

Bericht door believer »


believer
Forum elite
Forum elite
Berichten: 6451
Lid geworden op: 14 jan 2015 17:30
waarderingen: 4669

Re: Altimmune

Bericht door believer »


believer
Forum elite
Forum elite
Berichten: 6451
Lid geworden op: 14 jan 2015 17:30
waarderingen: 4669

Re: Altimmune

Bericht door believer »


believer
Forum elite
Forum elite
Berichten: 6451
Lid geworden op: 14 jan 2015 17:30
waarderingen: 4669

Re: Altimmune

Bericht door believer »

In a Phase 2 study, a 2.4 milligram dose of Altimmune’s (NASDAQ:ALT) GLP 1 drug, pemvidutide, lowered participants’ weight by an average of 15.6% — 13.4 percentage points more than those taking a placebo. That compares very favorably with the results of a study of Eli Lilly’s (NYSE:LLY) popular GLP-1 drug, in which those taking the medicine lost an average of 7.1% more weight than those taking a placebo.

Also noteworthy is that pemvidutide’s tolerability was reportedly better than that of other GLP 1 treatments. Finally, the drug’s reduced LDL cholesterol more than two other popular GLP 1 drugs, semaglutide and tirzepatide.

Given these points, the $538 million market capitalization of ALT stock far undervalues the shares, while the company could easily become a takeover target.


https://www.nasdaq.com/articles/stocks- ... loss-drugs

believer
Forum elite
Forum elite
Berichten: 6451
Lid geworden op: 14 jan 2015 17:30
waarderingen: 4669

Re: Altimmune

Bericht door believer »

ALT Drug Better Than Ozempic!!!!!

https://m.youtube.com/live/K3vLw92uD5A

Biedstrijd kan starten voor de grote pharma bedrijven
https://finance.yahoo.com/quote/ALT/









Plaats reactie